In the current study, we have demonstrated the supportive effects of brain-derived CCR5 on enhancing neurostructure remodeling in the peri-infarct cortex in the subacute phase of experimental stroke (2 months post-MACO). This evidence concerns the gene CCR5 and Stroke.